Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone coach after heart attack may slash cholesterol and save lives

NCT ID NCT06471036

Recruiting now Disease control Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether a 'care champion' — a person who calls patients after they leave the hospital following a heart attack or stent procedure — can help them get their LDL cholesterol to a healthy level. Participants also receive education for their doctors. The study compares cholesterol levels in patients who get the care champion calls versus those who do not, over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a care champion intervention (phone-based support and education)
What this could lead to
If successful, this approach could become a standard way to help heart patients manage their cholesterol after leaving the hospital, potentially reducing the risk of future heart attacks.
What could go wrong
This is an implementation trial testing a support system, not a new drug. The benefit may be modest, and results depend on patient engagement and health system factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCVD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis atherosclerotic cardiovascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASCVD LDL-C

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allina Health

    RECRUITING

    Minneapolis, Minnesota, 55407, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.